Core Scientific Inc CORZ.OQ CORZ.O is expected to show a fall in quarterly revenue when it reports results on August 5 (estimated) for the period ending June 30 2025
The Dover Delaware-based company is expected to report a 42.2% decrease in revenue to $81.588 million from $141.1 million a year ago, according to the mean estimate from 13 analysts, based on LSEG data.
LSEG's mean analyst estimate for Core Scientific Inc is for a loss of 8 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," 9 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Core Scientific Inc is $18.00, about 24.8% above its last closing price of $13.54
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.12
-0.11
1.25
Beat
1,279.2
Dec. 31 2025
-0.08
-0.08
-0.60
Missed
-616.6
Sep. 30 2024
-0.10
-0.09
-1.17
Missed
-1,179.5
Jun. 30 2024
0.02
0.03
-4.51
Missed
-14,193.7
Mar. 31 2024
0.13
0.13
0.16
Beat
23.1
This summary was machine generated August 1 at 12:42 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)